{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:25:21Z","timestamp":1791181521628,"version":"4.1.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0093635","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T20:43:57Z","timestamp":1396385037000},"page":"e93635","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features"],"prefix":"10.1371","volume":"9","author":[{"given":"Yung-Luen","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Jung","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ju","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shian-Shiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2217\/pme.11.15","article-title":"Genetic susceptibility to bladder cancer risk and outcome","volume":"8","author":"J Gu","year":"2011","journal-title":"Per Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ijc.10191","article-title":"Familial aggregation of urothelial cell carcinoma","volume":"98","author":"KK Aben","year":"2002","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","article-title":"Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines","volume":"59","author":"A Stenzl","year":"2011","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4161\/epi.20837","article-title":"DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status","volume":"7","author":"M Lauss","year":"2012","journal-title":"Epigenetics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00432-007-0288-8","article-title":"Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder","volume":"134","author":"S Hinz","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1093\/hmg\/ddm018","article-title":"Epigenetic gene silencing in cancer: the DNA hypermethylome","volume":"1","author":"M Esteller","year":"2007","journal-title":"Hum Mol Genet 16 Spec No"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ng.865","article-title":"Increased methylation variation in epigenetic domains across cancer types","volume":"43","author":"KD Hansen","year":"2011","journal-title":"Nat Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ng1950","article-title":"Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer","volume":"39","author":"Y Schlesinger","year":"2007","journal-title":"Nat Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2013.04.028","article-title":"EZH2: an epigenetic gatekeeper promoting lymphomagenesis","volume":"23","author":"H Heyn","year":"2013","journal-title":"Cancer Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mrfmmm.2008.07.010","article-title":"Roles of the EZH2 histone methyltransferase in cancer epigenetics","volume":"647","author":"JA Simon","year":"2008","journal-title":"Mutat Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","article-title":"EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells","volume":"100","author":"CG Kleer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1158\/0008-5472.CAN-11-3546","article-title":"Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer","volume":"72","author":"G Ren","year":"2012","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.stem.2010.08.002","article-title":"Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer","volume":"7","author":"M Sauvageau","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/onc.2008.333","article-title":"Repression of E-cadherin by the polycomb group protein EZH2 in cancer","volume":"27","author":"Q Cao","year":"2008","journal-title":"Oncogene"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.phrs.2003.05.002","article-title":"Pharmacogenetics of neoplastic diseases: new trends","volume":"49","author":"A Di Paolo","year":"2004","journal-title":"Pharmacol Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s100380200086","article-title":"SNP alleles in human disease and evolution","volume":"47","author":"BS Shastry","year":"2002","journal-title":"J Hum Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/annonc\/mdr387","article-title":"An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients","volume":"23","author":"F Crea","year":"2012","journal-title":"Ann Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/JTO.0b013e3181c422d9","article-title":"Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer","volume":"5","author":"KA Yoon","year":"2010","journal-title":"J Thorac Oncol"},{"key":"ref19","first-page":"365","article-title":"Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression","volume":"36","author":"YL Yu","year":"2010","journal-title":"Int J Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1423-0127-16-47","article-title":"Immunotherapy: rAAV2 expressing interleukin-15 inhibits HeLa cell tumor growth in mice","volume":"16","author":"GT Yiang","year":"2009","journal-title":"J Biomed Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e39466","DOI":"10.1371\/journal.pone.0039466","article-title":"Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma","volume":"7","author":"CS Wu","year":"2012","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jcp.22719","article-title":"Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells","volume":"227","author":"YL Yu","year":"2012","journal-title":"J Cell Physiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nsmb.2489","article-title":"Epigenetic programming and reprogramming during development","volume":"20","author":"I Cantone","year":"2013","journal-title":"Nat Struct Mol Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"31015","DOI":"10.1074\/jbc.M112.358077","article-title":"Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776","volume":"287","author":"YL Yu","year":"2012","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1158\/1078-0432.CCR-05-1047","article-title":"Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder","volume":"11","author":"JD Raman","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000087804","article-title":"Increased expression of EZH2, a polycomb group protein, in bladder carcinoma","volume":"75","author":"S Arisan","year":"2005","journal-title":"Urol Int"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/carcin\/bgr083","article-title":"Impact of RECK gene polymorphisms and environmental factors on oral cancer susceptibility and clinicopathologic characteristics in Taiwan","volume":"32","author":"TT Chung","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","author":"C International HapMap","year":"2003","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.ejhg.5200439","article-title":"The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders","volume":"8","author":"C Cardoso","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/carcin\/bgn283","article-title":"Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese","volume":"30","author":"YT Chung","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.ejhg.5201164","article-title":"Detection of genotyping errors by Hardy-Weinberg equilibrium testing","volume":"12","author":"L Hosking","year":"2004","journal-title":"Eur J Hum Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0093635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T01:41:15Z","timestamp":1540258875000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0093635"}},"subtitle":[],"editor":[{"given":"Robert","family":"Lafrenie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0093635","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}